Wordt geladen...
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same? A Narrative Review of Cardiovascular Outcome Trials
Clinically important improvements in cardiovascular risk factors and adverse cardiovascular, heart failure and renal outcomes have been observed in numerous cardiovascular outcome trials (CVOTs) investigating the use of sodium-glucose co-transporter 2 (SGLT2) inhibitors over the last 5 years. Howeve...
Bewaard in:
| Gepubliceerd in: | Diabetes Ther |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer Healthcare
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7843788/ https://ncbi.nlm.nih.gov/pubmed/33185854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00951-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|